We’re tackling the disease from all sides, with our sights on elimination

More than 650,000 people, mostly children, will die from malaria this year. The majority of them live in sub-Saharan Africa, where each day a mosquito’s bite devastates families, threatens communities, and draws resources away from other pressing health needs.

But malaria can be stopped. PATH has the tools at hand to tackle the disease from all sides and to save lives today and tomorrow.

To help people who are suffering from malaria right now, we have developed a stable supply of the drug at the heart of the best available malaria treatment. To support countries in preventing, controlling, and eventually eliminating the parasite region by region, we’re introducing innovative methods—from new approaches for diagnosing illness to intensive tracking of malaria cases. And to banish malaria altogether, we’re providing scientific expertise and crucial leverage to drive the development of the world’s first malaria vaccine.

Our work is paying off: fewer people are dying of malaria. But the disease still sickens more than 200 million people every year.

PATH’s strong partnerships, inventive approaches, and proven successes uniquely position us to see the future of malaria—and to move toward a world where malaria no longer exists.

Photo: PATH/Laura Newman.